Home/Filings/4/0001213900-19-027008
4//SEC Filing

Rubini Jonathan Brian 4

Accession 0001213900-19-027008

CIK 0001218683other

Filed

Dec 25, 7:00 PM ET

Accepted

Dec 26, 4:31 PM ET

Size

6.9 KB

Accession

0001213900-19-027008

Insider Transaction Report

Form 4
Period: 2019-12-20
Transactions
  • Purchase

    Common Stock

    2019-12-20$0.27/sh+2,037,037$550,0002,455,739 total
  • Purchase

    Warrants

    2019-12-20+4,074,0474,074,047 total
    Exercise: $0.27Exp: 2024-12-19Common Stock (4,074,047 underlying)
Footnotes (1)
  • [F1]Exercisable five days following the public announcement of positive clinical data results for LO2A

Issuer

Wize Pharma, Inc.

CIK 0001218683

Entity typeother

Related Parties

1
  • filerCIK 0001723667

Filing Metadata

Form type
4
Filed
Dec 25, 7:00 PM ET
Accepted
Dec 26, 4:31 PM ET
Size
6.9 KB